Target intelligence / Profile preview

Prothymosin alpha pseudogene 1 (PTMAP1)

Target
PTMAP1
Molecular classification
Other (Pseudogene)
01

Overview

**Prothymosin alpha pseudogene 1 (PTMAP1)** is a processed pseudogene within the human prothymosin alpha gene family. Unlike the functional prothymosin alpha gene (PTMA), PTMAP1 does not have documented expression evidence nor established protein product, and is considered non-functional. It differs significantly in its coding sequence due to insertions, deletions, and an upstream translation initiation site. Studies analyzing mRNA from human tissues have not found transcripts specific to PTMAP1, supporting its classification as a pseudogene with no known biological activity or therapeutic target potential[1][4][9]. **Key interpretation notes:** - PTMAP1 is not a protein-coding gene and is classified as a pseudogene, not a receptor, enzyme, or any conventional drug target[1][9]. - The functional gene of interest for prothymosin alpha biology is PTMA, not PTMAP1. All known biological functions, clinical significance, and therapeutic interactions are attributed to PTMA or its protein product, prothymosin alpha—not this pseudogene[3][5][6]. - No drug interactions, disease roles, or molecular mechanisms are associated with PTMAP1, consistent with its pseudogene classification[1][9].

Other names
Em:AB023049.6PTMAP1

Beyond the preview

Go deeper on Prothymosin alpha pseudogene 1 (PTMAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prothymosin alpha pseudogene 1 (PTMAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call